Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian stock markets open firm
Tue, 31 Jan 09:30 am

Most Asian stock markets have opened the day on a firm note with stock markets in Taiwan (up 1%) and Hong Kong (up 0.7%) trading firm. However, markets in Singapore (down 0.3%) are trading in the red. The Indian stock markets have opened the day on a firm note. Stocks in the banking and realty space are leading the gains.

The BSE-Sensex is trading higher by 173 points (1%), while the NSE-Nifty is up by around 55 points (1.1%). Mid cap and small cap stocks are also trading in the green with the BSE Mid cap and BSE Small cap indices up by 0.9% and 0.8% respectively. The rupee is trading at 49.68 to the US dollar.

Pharma stocks have opened the day on a firm note with Dishman Pharma and Orchid Chemicalsleading the gains. Biocon has announced its third quarter results for 2011-2012 (3QFY12). The company has reported 1.5% year-on-year (YoY) increase in sales and 13.8% YoY decrease in net profits. Net sales grew at a meagre 1.5% YoY due to a sharp decline in the licensing income and lower sales growth from Biopharma business. Biocon reported 729 bps YoY (7.3%) decline in operating margins to 24.6% mainly due to the increase in raw material costs and staff expenses. The raw material cost went up by 470 bps (4.7%) YoY due to lower licensing income and the staff costs went up by 300 bps (3%) YoY due to increase in the number of employees which is currently over 6,000. Excluding AxiCorp, net profits declined by 13.8% YoY owing to lower licensing income.

Engineering stocks have opened the day on a firm note with Ingersoll Rand and Suzlon Energy leading the gains. Bharat Heavy Electricals (BHEL) has announced its third quarter results for the financial year 2011-2012 (3QFY12). The company reported Rs 105 bn in net sales during the quarter, a 19% year-on-year (YoY) rise. While the power segment grew by 58% YoY, the industry segment witnessed a decline of 37% YoY. High raw material costs and other expenditure caused operating margins to decline from 23.4% in 3QFY11 to 19.7% in 3QFY12. At the bottomline level, the company reported net profits of Rs 14 bn, a mere 2% YoY rise. Net margins contracted from 15.9% in 3QFY11 to 13.6% in 3QFY12. At the end of the quarter, the company's order book stood at Rs 1.46 trillion, down 9% on a quarter-on-quarter basis.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets open firm". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.